Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Expression of FOXP3 in edited CD34+ cells

Expression of FOXP3 in edited CD34+ cells

US Patent 11713459 · Granted Aug 1, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vivo gene therapy using intraosseous delivery of a lentiviralgene construct2025
Homology directed repair compositions for the treatment of hemoglobinopathies2025
Homology directed repair compositions for the treatment of hemoglobinopathies2025
Coupling endonucleases with end-processing enzymes drives high efficiency gene d2025
Methods of exogenous drug activation of chemical-induced signaling complexes exp2025
Optimized mRNA encoding CAS9 for use in LNPs2025
Viral vectors and packaging cell lines2025
Homology directed repair compositions for the treatment of hemoglobinopathies2024
Homology directed repair compositions for the treatment of hemoglobinopathies2024
Rapamycin resistant cells2024
Rapamycin resistant cells2024
Rapamycin resistant cells2024